SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 microgrammes/25 microgrammes, dispersion injectable. Vaccin à ARNm contre la COVID-19 — 10 flacon(s) unidose(s) en verre (10 doses)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930266472 -
CIP7
3026647 -
CIS
69556437 -
Registration number
EU/1/20/1507
What the source publishes
- Holder
- MODERNA BIOTECH SPAIN SL (ESPAGNE)
- Active ingredients
- ÉLASOMÉRAN, DAVESOMÉRAN
- Form
- dispersion injectable
- Package
- 10 flacon(s) unidose(s) en verre (10 doses)
- Routes
- intramusculaire
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2022-12-16
- Prescription
- Prescription or restricted
Names this record is found by
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 microgrammes/25 microgrammes, dispersion injectable. Vaccin à ARNm contre la COVID-19 — 10 flacon(s) unidose(s) en verre (10 doses)
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 microgrammes/25 microgrammes, dispersion injectable. Vaccin à ARNm contre la COVID-19
- ÉLASOMÉRAN
- DAVESOMÉRAN
Complete source data
{
"cis": "69556437",
"cip7": "3026647",
"form": "dispersion injectable",
"name": "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 microgrammes/25 microgrammes, dispersion injectable. Vaccin à ARNm contre la COVID-19 — 10 flacon(s) unidose(s) en verre (10 doses)",
"cip13": "3400930266472",
"holder": "MODERNA BIOTECH SPAIN SL (ESPAGNE)",
"routes": [
"intramusculaire"
],
"holders": [
"MODERNA BIOTECH SPAIN SL (ESPAGNE)"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2022-12-16",
"compositions": [
{
"name": "ÉLASOMÉRAN",
"nature": "SA",
"strength": "25 microgrammes",
"linkageNumber": "1",
"substanceCode": "43288",
"dosageReference": "une dose de 0,5 mL",
"pharmaceuticalElement": "dispersion"
},
{
"name": "DAVESOMÉRAN",
"nature": "SA",
"strength": "25 microgrammes",
"linkageNumber": "2",
"substanceCode": "79258",
"dosageReference": "une dose de 0,5 mL",
"pharmaceuticalElement": "dispersion"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 microgrammes/25 microgrammes, dispersion injectable. Vaccin à ARNm contre la COVID-19",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "10 flacon(s) unidose(s) en verre (10 doses)",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2023-10-31",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ÉLASOMÉRAN",
"DAVESOMÉRAN"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/20/1507",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930266472"